ANASCORP
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
66621-0150 -
Package NDC
66621-0150-2 -
Application number
BLA125335 -
SPL ID
d0c33dec-842e-4cc0-9d8f-515d6efd8a0c -
SPL set ID
5cb65048-a30c-48e5-8bc8-897983d08068 -
UNII
DDA050FCEA -
RxCUI
1119989 -
RxCUI
1119993
What the source publishes
- Labeler
- Rare Disease Therapeutics, Inc
- Active ingredients
- centruroides (scorpion) immune F(ab)2 (equine)
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- PLASMA DERIVATIVE
Names this record is found by
Complete source data
{
"name": "ANASCORP",
"splId": "d0c33dec-842e-4cc0-9d8f-515d6efd8a0c",
"labels": [
{
"setId": "5cb65048-a30c-48e5-8bc8-897983d08068",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cb65048-a30c-48e5-8bc8-897983d08068",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5cb65048-a30c-48e5-8bc8-897983d08068"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Rare Disease Therapeutics, Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 CARTON (66621-0150-2) / 10 mL in 1 VIAL (66621-0150-1)",
"package_ndc": "66621-0150-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20110803"
}
],
"productId": "66621-0150_d0c33dec-842e-4cc0-9d8f-515d6efd8a0c",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "66621-0150",
"deaSchedule": null,
"genericName": "centruroides (scorpion) immune F(ab)2 (equine)",
"productType": "PLASMA DERIVATIVE",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CENTRUROIDES FAB2 ANTIVENIN (EQUINE)",
"strength": "7 mg/mL"
}
],
"applicationNumber": "BLA125335",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20110803",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {
"nui": [
"N0000184162",
"N0000183365",
"N0000184010",
"M0001517"
],
"upc": [
"0366621015022",
"0366621015015"
],
"unii": [
"DDA050FCEA"
],
"rxcui": [
"1119989",
"1119993"
],
"spl_set_id": [
"5cb65048-a30c-48e5-8bc8-897983d08068"
],
"pharm_class_cs": [
"Antivenins [CS]"
],
"pharm_class_pe": [
"Passively Acquired Immunity [PE]"
],
"pharm_class_epc": [
"Antivenin [EPC]"
],
"pharm_class_moa": [
"Venom Neutralization [MoA]"
],
"manufacturer_name": [
"Rare Disease Therapeutics, Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:66621-0150_d0c33dec-842e-4cc0-9d8f-515d6efd8a0c"